Berberine Slows the Progression of Prediabetes to Diabetes in Zucker Diabetic Fatty Rats by Enhancing Intestinal Secretion of Glucagon-Like Peptide-2 and Improving the Gut Microbiota

Anti-inflammatory activity of berberine in non-alcoholic fatty liver disease via the Angptl2 pathway

(2020) Zengsheng Lu et al.   BMC IMMUNOLOGY

The Firmicutes/Bacteroidetes Ratio: A Relevant Marker of Gut Dysbiosis in Obese Patients?

(2020) Fabien Magne et al.   Nutrients

Impact of Gut Microbiota on Host Glycemic Control

(2019) Céline Gérard et al.   Frontiers in Endocrinology

Effects of berberine on glucose-lipid metabolism, inflammatory factors and insulin resistance in patients with metabolic syndrome

(2019) Changfu Cao et al.   Experimental and Therapeutic Medicine

Investigation of dose-dependent effects of berberine against renal ischemia/reperfusion injury in experimental diabetic rats

(2019) Meltem Kumaş et al.   NEFROLOGIA

Evidence and Potential Mechanisms of Traditional Chinese Medicine for the Treatment of Type 2 Diabetes: A Systematic Review and Meta‐analysis

(2019) Jiaxing Tian et al.   DIABETES OBESITY & METABOLISM

Berberine chloride ameliorated PI3K/Akt‐p/SIRT‐1/PTEN signaling pathway in insulin resistance syndrome induced in rats

(2019) Marwa El‐Zeftawy et al.   JOURNAL OF FOOD BIOCHEMISTRY

Huang-Lian Jie-Du decoction: a review on phytochemical, pharmacological and pharmacokinetic investigations

(2019) Yiyu Qi et al.   Chinese Medicine

The Gut Microbiome as a Target for the Treatment of Type 2 Diabetes

(2018) Ömrüm Aydin et al.   Current Diabetes Reports

IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045

(2018) N.H. Cho et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Aberrant intestinal microbiota in individuals with prediabetes

(2018) Kristine H. Allin et al.   DIABETOLOGIA

Berberine Modulates Gut Microbiota and Reduces Insulin Resistance via the TLR4 Signaling Pathway

(2018) Dan Liu et al.   EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES

The Gut Microbiome Profile in Obesity: A Systematic Review

(2018) Olga Castaner et al.   International Journal of Endocrinology

A Glucagon-Like Peptide-1 Receptor Agonist Lowers Weight by Modulating the Structure of Gut Microbiota

(2018) Li Zhao et al.   Frontiers in Endocrinology

Berberine alleviates insulin resistance by reducing peripheral branched-chain amino acids

(2018) Shi-Jun Yue et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Disclosures: Standards of Medical Care in Diabetes—2019

(2018)   DIABETES CARE

Thromboxane-Dependent Platelet Activation in Obese Subjects with Prediabetes or Early Type 2 Diabetes: Effects of Liraglutide- or Lifestyle Changes-Induced Weight Loss

(2018) Paola Simeone et al.   Nutrients

3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial

(2017) Carel W le Roux et al.   LANCET

Berberine protects against diet-induced obesity through regulating metabolic endotoxemia and gut hormone levels

(2017) Jian Hui Xu et al.   Molecular Medicine Reports

Effect of berberine on the renal tubular epithelial-to-mesenchymal transition by inhibition of the Notch/snail pathway in diabetic nephropathy model KKAy mice

(2017) Guannan Yang et al.   Drug Design Development and Therapy

Metformin and berberine, two versatile drugs in treatment of common metabolic diseases

(2017) Haoran Wang et al.   Oncotarget

New Insights into the Mechanisms of Chinese Herbal Products on Diabetes: A Focus on the “Bacteria-Mucosal Immunity-Inflammation-Diabetes” Axis

(2017) Zezheng Gao et al.   Journal of Immunology Research

Gastrointestinal defense mechanisms

(2016) Hyder Said et al.   CURRENT OPINION IN GASTROENTEROLOGY

The Therapeutic Effect of Berberine in the Treatment of Nonalcoholic Fatty Liver Disease: A Meta-Analysis

(2016) Xiaoyun Wei et al.   Evidence-based Complementary and Alternative Medicine

Research progress on berberine with a special focus on its oral bioavailability

(2016) Chang-Shun Liu et al.   FITOTERAPIA

GLP2: an underestimated signal for improving glycaemic control and insulin sensitivity

(2016) Antonella Amato et al.   JOURNAL OF ENDOCRINOLOGY

Human gut microbes impact host serum metabolome and insulin sensitivity

(2016) Helle Krogh Pedersen et al.   NATURE

Protective Effects of Bifidobacterium on Intestinal Barrier Function in LPS-Induced Enterocyte Barrier Injury of Caco-2 Monolayers and in a Rat NEC Model

(2016) Xiang Ling et al.   PLoS One

Berberine prevents progression from hepatic steatosis to steatohepatitis and fibrosis by reducing endoplasmic reticulum stress

(2016) Zhiguo Zhang et al.   Scientific Reports

Postprandial glucagon-like peptide-1 secretion is increased during the progression of glucose intolerance and obesity in high-fat/high-sucrose diet-fed rats

(2015) Shingo Nakajima et al.   BRITISH JOURNAL OF NUTRITION

Application of Berberine on Treating Type 2 Diabetes Mellitus

(2015) Bing Pang et al.   International Journal of Endocrinology

The CNS glucagon-like peptide-2 receptor in the control of energy balance and glucose homeostasis

(2014) Xinfu Guan   AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY

Effects of high-fat diet and the anti-diabetic drug metformin on circulating GLP-1 and the relative number of intestinal L-cells

(2014) Camilla Kappe et al.   Diabetology & Metabolic Syndrome

Enteral supplementation with glutamine, fiber, and oligosaccharide modulates incretin and glucagon-like peptide-2 secretion

(2014) Erina Joo et al.   Journal of Diabetes Investigation

Physiology and Pharmacology of the Enteroendocrine Hormone Glucagon-Like Peptide-2

(2013) Daniel J. Drucker et al.   Annual Review of Physiology

Global estimates of diabetes prevalence for 2013 and projections for 2035

(2013) L. Guariguata et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Update on Berberine in Nonalcoholic Fatty Liver Disease

(2013) Yang Liu et al.   Evidence-based Complementary and Alternative Medicine

An increase in theAkkermansiaspp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice

(2013) Na-Ri Shin et al.   GUT

Prevalence and Control of Diabetes in Chinese Adults

(2013) Yu Xu   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Alteration of the intestinal barrier and GLP2 secretion in Berberine-treated type 2 diabetic rats

(2013) C Y Shan et al.   JOURNAL OF ENDOCRINOLOGY

Maternal Ileal Interposition Surgery Confers Metabolic Improvements to Offspring Independent of Effects on Maternal Body Weight in UCD-T2DM Rats

(2013) Bethany P. Cummings et al.   OBESITY SURGERY

Is there a place for incretin therapies in obesity and prediabetes?

(2013) Jens Juul Holst et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Prediabetes: a high-risk state for diabetes development

(2012) Adam G Tabák et al.   LANCET

Modulation of glucagon-like peptide-1 release by berberine: In vivo and in vitro studies

(2009) Yunli Yu et al.   BIOCHEMICAL PHARMACOLOGY

Diabetes in Asia

(2009) Juliana C. N. Chan et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Diabetes in Asia

(2009) Ambady Ramachandran et al.   LANCET

Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression

(2009) Hao Zhang et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Berberine promotes glucagon-like peptide-1 (7–36) amide secretion in streptozotocin-induced diabetic rats

(2008) Shou-Si Lu et al.   JOURNAL OF ENDOCRINOLOGY

Efficacy of berberine in patients with type 2 diabetes mellitus

(2008) Jun Yin et al.   METABOLISM-CLINICAL AND EXPERIMENTAL